-
C & G Manufacturing
-
Gene Therapy Development
What are the key drivers behind the growing interest in non-oncological gene therapies and Which non
...
-
Cell Therapy Development
Can we modulate the immunosuppressive tumor microenvironment effectively? Can we engineer resilient
...
-
Gene Therapy Development
Control arm in pivotal studies – is Placebo necessary and/or ethical? Clinical endpoints borrowed fr
...
-
Gene Therapy Development
How do we alter/construct preclinical data packages to assess the risk of delayed adverse events and
...
-
C & G Bioprocessing
Key considerations to implement new technology in cell & gene therapy manufacturing? How to overcome
...
-
Cell & Gene Manufacturing
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Afternoon Refreshments
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Morning Refreshments
-
C & G Manufacturing
What are the most important critical quality attributes (CQAs) for gene therapy products? Should the
...
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Evening Drinks Reception
-
C & G Bioprocessing
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
1-2-1 Meetings / Networking Break
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
1-2-1 Meetings / Networking Break
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Networking Lunch
-
Cell Therapy Development
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
1-2-1 Meetings / Networking Break
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
1-2-1 Meetings / Networking Break
-
C & G Bioprocessing
What are some of the critical considerations while designing processes for early stage CGT products?
...
-
Cell Therapy Development
What preclinical characteristics are most convincing that an IPSC-derived cell therapy will be optim
...
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Potency assays measure the biological activity of biological products, providing data on drug dose,
...
-
-
C & G Bioprocessing
-
Cell Therapy Development
-
C & G Manufacturing
-
Gene Therapy Development
Registration
)
Potency assays measure the biological activity of biological products, providing data on drug dose, ...
)
)
)
)
)
)
)
)
)
)
)